Oscar Health (NYSE:OSCR) Rating Lowered to "Sell" at Wall Street Zen

Key Points

• Oscar Health has been downgraded from a "hold" to a "sell" rating by analysts at Wall Street Zen, marking a negative shift in investor sentiment.
• Multiple analysts have reduced their price targets for Oscar Health's stock, with Wells Fargo cutting it from $16.00 to $10.00 and Barclays lowering it from $17.00 to $11.00.
• The stock is currently trading at $15.43, with an average target price of $12.21 and a high of $23.79 and low of $11.20 in the past year.

Oscar Health (NYSE:OSCR - Get Free Report) was downgraded by stock analysts at Wall Street Zen from a "hold" rating to a "sell" rating in a report issued on Saturday.

A number of other equities analysts also recently commented on the stock. Baird R W downgraded shares of Oscar Health from a "strong-buy" rating to a "hold" rating in a research note on Friday, July 25th. Wells Fargo & Company cut shares of Oscar Health from an "equal weight" rating to an "underweight" rating and lowered their price target for the stock from $16.00 to $10.00 in a report on Friday, July 11th. UBS Group reiterated a "sell" rating and set a $11.00 price target (down previously from $15.00) on shares of Oscar Health in a report on Tuesday, July 15th. Barclays reduced their price objective on shares of Oscar Health from $17.00 to $11.00 and set an "underweight" rating for the company in a research report on Wednesday, July 23rd. Finally, Robert W. Baird reiterated a "neutral" rating and issued a $14.00 price target (down previously from $28.00) on shares of Oscar Health in a research report on Friday, July 25th. Six equities research analysts have rated the stock with a sell rating and four have given a hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Reduce" and a consensus price target of $12.21.

Oscar Health Price Performance

Shares of Oscar Health stock traded up $0.27 during trading hours on Friday, reaching $15.43. The company's stock had a trading volume of 16,244,433 shares, compared to its average volume of 33,154,650. The firm has a 50 day moving average price of $15.90 and a 200-day moving average price of $14.84. Oscar Health has a one year low of $11.20 and a one year high of $23.79. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.86 and a quick ratio of 0.86. The stock has a market cap of $3.93 billion, a P/E ratio of -19.05 and a beta of 1.86.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its earnings results on Wednesday, August 6th. The company reported ($0.89) EPS for the quarter, beating analysts' consensus estimates of ($0.90) by $0.01. The company had revenue of $2.86 billion during the quarter, compared to analysts' expectations of $2.88 billion. Oscar Health had a negative net margin of 1.50% and a negative return on equity of 13.78%. Oscar Health's revenue for the quarter was up 29.0% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.20 earnings per share. On average, analysts predict that Oscar Health will post 0.69 EPS for the current year.

Insider Activity at Oscar Health

In other Oscar Health news, Director Elbert O. Jr. Robinson sold 25,000 shares of the stock in a transaction on Monday, May 12th. The stock was sold at an average price of $16.43, for a total transaction of $410,750.00. Following the transaction, the director owned 64,512 shares in the company, valued at $1,059,932.16. This trade represents a 27.93% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 25.11% of the company's stock.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its position in Oscar Health by 3.7% during the 1st quarter. Vanguard Group Inc. now owns 19,698,442 shares of the company's stock worth $258,247,000 after buying an additional 700,469 shares during the period. Deerfield Management Company L.P. Series C increased its position in shares of Oscar Health by 50.7% in the fourth quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company's stock worth $159,062,000 after purchasing an additional 3,983,325 shares during the period. T. Rowe Price Investment Management Inc. increased its position in shares of Oscar Health by 4.1% in the first quarter. T. Rowe Price Investment Management Inc. now owns 11,826,245 shares of the company's stock worth $155,043,000 after purchasing an additional 467,301 shares during the period. Thrive Capital Management LLC increased its position in shares of Oscar Health by 33.4% in the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock worth $85,258,000 after purchasing an additional 1,588,395 shares during the period. Finally, Gilder Gagnon Howe & Co. LLC increased its position in shares of Oscar Health by 51.4% in the fourth quarter. Gilder Gagnon Howe & Co. LLC now owns 6,335,862 shares of the company's stock worth $85,154,000 after purchasing an additional 2,151,256 shares during the period. Institutional investors own 75.70% of the company's stock.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.